Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

651
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
651
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

739
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
739
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

710
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
710
Survival Tree01:19

Survival Tree

496
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
496
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

488
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
488
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between depression, anxiety, sleep disturbances and dementia: a prospective cohort study of 350,186 adults.

BMC neurology·2026
Same author

Semi-Supervised Learning to Improve Generalizability of Cancer Associated-Venous Thromboembolism Risk Prediction Models.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same author

Analysis of α-synuclein seed amplification assay in carriers of <i>GBA1</i> and <i>LRRK2</i> pathogenic variants.

Journal of Parkinson's disease·2026
Same author

A novel accumulative modelling method using temporal images: Concept proposal and clinical validation on multiple diseases.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Long-term exposures to PM<sub>2.5</sub> components increase the breast cancer mortality in the region of Inner Mongolia, China: a retrospective study based on mixture cure model.

BMC cancer·2025
Same author

A comprehensive comparison of third generation epidermal growth factor receptor tyrosine kinase inhibitors in the treatment efficacy and adverse events: A Bayesian meta-analysis.

Global medical genetics·2025

Related Experiment Video

Updated: Apr 2, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data.

Yuanjia Wang1, Baosheng Liang2, Xingwei Tong3

  • 1Department of Biostatistics, Mailman School of Public Health, 722 W168th Street, New York 10032, U.S.A. yw2016@columbia.edu.

Biometrika
|September 29, 2015
PubMed
Summary
This summary is machine-generated.

This study introduces a faster, efficient method for estimating genetic disease risk, particularly for complex disorders with censored data and unknown mutation statuses. The new approach improves accuracy in predicting age-at-onset for carriers of causal mutations.

Keywords:
Empirical processMixture distributionParkinson's diseaseSemiparametric efficiencySieve maximum likelihood estimation

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Related Experiment Videos

Last Updated: Apr 2, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Area of Science:

  • Genetics
  • Epidemiology
  • Biostatistics

Background:

  • Assessing genetic risk for complex human disorders is vital.
  • Causal gene mutations influence disease onset and require accurate risk estimation.
  • Censored age-at-onset data and unknown mutation statuses present challenges in genetic studies.

Purpose of the Study:

  • To develop an efficient method for estimating nonparametric distributions of age-at-onset in the presence of censored data and missing mutation statuses.
  • To improve risk estimation for individuals carrying causal mutations for complex diseases.

Main Methods:

  • Proposed a fully efficient sieve maximum likelihood estimation method.
  • Utilized B-splines for estimating the hazard ratio logarithm between genetic mutation groups.
  • Employed nonparametric maximum likelihood estimation for the baseline hazard function.
  • Developed an expectation-maximization algorithm for faster computation.

Main Results:

  • The proposed estimator is consistent and semiparametrically efficient.
  • Established the asymptotic distribution of the new estimator.
  • Simulation studies demonstrated superior performance compared to existing methods.
  • Applied the method to estimate age-at-onset distribution for Parkinson's disease mutation carriers (LRRK2 gene).

Conclusions:

  • The novel sieve maximum likelihood estimation method offers an efficient and accurate approach for genetic risk assessment.
  • This method effectively handles censored data and missing mutation status, outperforming previous techniques.
  • The findings have significant implications for understanding disease progression in carriers of specific genetic mutations, exemplified by Parkinson's disease research.